Table 2.

Adjusted mean systolic and diastolic blood pressure (BP) and systolic and diastolic BP decreases after the addition of trandolapril to verapamil sustained release monotherapy in different races/ethnicities according to AGTR1 1166 A→C genotype (n = 551)

	Adjusted Systolic/Diastolic BP (mm Hg)
	A/A	C Allele Carriers	p Value (systolic/diastolic BP)
White	139.9 ± 2.5/77.7 ± 1.4	141.0 ± 2.4/79.5 ± 1.4	0.63/0.12
Black	143.9 ± 6.3/82.8 ± 3.3	137.1 ± 7.8/80.1 ± 4.1	0.22/0.36
Hispanic	144.6 ± 2.7/85.3 ± 1.4	141.3 ± 3.0/83.9 ± 1.2	0.11/0.19
	Systolic/Diastolic BP Decrease (mm Hg)
	A/A	C Allele Carriers	p Values (systolic/diastolic BP decrease)
White	−8.5 ± 2.5/−5.6 ± 1.4	−7.4 ± 2.4/−3.7 ± 1.4	0.63/0.16
Black	−7.0 ± 6.3/−3.1 ± 3.4	−13.9 ± 7.8/−6.3 ± 4.2	0.22/0.29
Hispanic	−3.3 ± 2.7/−0.5 ± 1.4	−6.6 ± 3.0/−1.9 ± 1.5	0.11/0.12

C Allele carriers were combined in 1 group. p Values were adjusted for multiple comparisons. Results presented as mean ± SE.